Company Comparison
Pardes Biosciences vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Pardes Biosciences | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | — |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | — | — |
| Total Funding | — | — |
| Valuation | — | — |
What They Build
Pardes Biosciences
Clinical-stage biopharmaceutical company developing oral antiviral therapeutics for infectious diseases.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
Pardes Biosciences
No investors listed.
Sector Overlap
Both Pardes Biosciences and 10x Genomics operate in Biotech.
Browse all Biotech companies →